首頁 產業/市場分類 出版商一覽 Email 通知 GII媒體代理會議 公司簡介 聯絡我們
- English Japanese Korean
首頁 > 市場調查報告書 > 製藥 > 製藥企業 > 全球醫療相關企業各企業間的合作:2006 年版 第一卷
產業/市場分類
製藥 (4495)
肥胖症治療 (48)
非專利藥 (117)
疫苗 (168)
神經疾病 (175)
骨頭疾病治療 (41)
動物用醫藥 (18)
處方藥 (89)
規章 (107)
感染疾病 (318)
精神病 (80)
製藥企業 (506)
糖尿病 (157)
癌症 (838)
藥物開發 (1275)
DDS (173)
OTC 非處方藥 (147)
市場調查報告書

全球醫療相關企業各企業間的合作:2006 年版 第一卷

Partneringreview 2006 - Company deal index (volume 1)

出版商 Pharmalicensing Ltd.
出版日期 2006年02月 商品編碼 36675
內容資訊 英文 1852 pages
價格
US $ 2495 PDF by E-mail (Single User License)


全球醫療相關企業各企業間的合作:2006 年版 第一卷 是由出版商Pharmalicensing Ltd.在2006年02月所出版的。 這份英文市場調查報告書包含1852 pages 價格從美金2495起跳。

簡介

2005 年生技藥物領域的企業合併與吸收持續進展,件數達到 230 件,較 2004、2003 年的 170、150 件都來得多。

專研製藥、生技、保健領域,素有好評的英國市調公司 Bridgehead International Limited(總公司:英國雷斯塔夏),調查分析了 2005 年全球醫療相關企業間的合作狀況後,出版了一本綜合報告書 "Partneringreview 2006 - Company deal index (volume 1)"

本報告書為全系列六卷中的第一卷,內容包含 2005 年發表的企業合併、吸收、資金合作,以列表標示,內容綱要摘記如下:

第1章 各企業之企業合作

第2章 各企業收購與合併

第3章 合作列表

調查對象(舉例)

  • Pfizer
  • GlaxoSmithKline
  • Sanofi-Aventis
  • Johnson & Johnson
  • Merck
  • Novartis
  • AstraZeneca
  • Roche
  • Bristol-Myers Squibb
  • Wyeth
  • Abbott Labs
  • Eli Lilly
  • Amgen
  • 武田藥品工業
  • Boehringer Ingelheim
  • Schering-Plough
  • Schering AG
  • Bayer
  • Eisai
  • Teva
  • Merck KGaA
  • Yamanouchi(今 Astellas)
  • 大塚製藥
  • Novo Nordisk
  • Baxter
  • Fujisawa(今 Astellas)
  • 三共
  • Forest Labs
  • Akzo Nobel
  • Altana
  • Serono
  • Solvay
  • UCB
  • Genzyme
  • Allergan
  • 三菱 Pharma
  • 鹽野義製藥
  • Watson
  • IVAX
  • Alcon
  • H Lundbeck
  • Biogen Idec
  • Mylan Labs
  • Shire
  • 小野藥品
  • 田邊製藥
  • 第一製藥
  • Barr
  • Gilead Sciences
  • Purdue Pharma

目錄

Abstract

Partneringreview 2006 - Volume 1: Company deal index provides an in depth view into the deals by company, with a full index of all the deals, including mergers, acquisitions and financings announced in 2005. A clear and easy way to see the activities of any company.

Every deal by every company listed alphabetically.

Every deal is fully categorized, includes a detailed description, and includes financials such as headline value, upfront and milestone payments, where disclosed.

Each deal is annotated with a deal number, such as #43. This number links to the full deal in the deal listing at the rear of each report. When using the PDF format in Acrobat Reader, simply click on the number to move around the report.

The report includes the deals announced by hundreds of companies including the top 50 biopharma: Pfizer, GlaxoSmithKline, Sanofi-Aventis, Johnson & Johnson, Merck, Novartis, AstraZeneca, Roche, Bristol-Myers Squibb, Wyeth, Abbott Labs, Eli Lilly, Amgen, Takeda, Boehringer Ingelheim, Schering-Plough, Schering AG, Bayer, Eisai, Teva, Merck KGaA, Yamanouchi, Otsuka, Novo Nordisk, Baxter, Fujisawa, Sankyo, Forest Labs, Akzo Nobel, Altana, Serono, Solvay, UCB, Genzyme, Allergan, Mitsubishi Pharma, Shionogi, Watson, IVAX, Alcon, H Lundbeck, Biogen Idec, Mylan Labs, Shire, Ono, Tanabe Seiyaku, Daiichi, Barr, Gilead Sciences, Purdue Pharma.

All the year' s deals at a glance.

Want to know what your competitors are doing? Want to benchmark your deals against others in your therapeutic area or see how the finances of different deal types compare? Partneringreview 2006 brings all the 2005' s deals into focus in one place.

Partneringreview is a comprehensive summary of the year' s deal announcements in a clear and accessible printable format. Every deal entry includes financial information where disclosed, such as headline values and upfront and milestone payments. A new addition of an overview of financings from investors is also included in this latest edition.

Partneringreview 2006 is the full report of all the deals data collected in 2005, providing a broad perspective of deal announcements, and incorporates all six volumes.

Table of Contents

INTRODUCTION

  • About Partneringreview
  • Full contents of Partneringreview 2006
  • Review of deal making in 2005
  • Deals announced by company

VOLUME 1: COMPANY DEAL INDEX

  • Chapter 1: Deals by company
  • Chapter 2: M&A by company
  • Chapter 3: List of deals

GLOSSARY

List of tables, charts

Figures

  • Figure i.1 Partnering announcements by company 2004 vs 2005
  • Figure i.2 Top 25 pharma deal activity 2004 vs 2005
Back to Top